Plasminogen activator inhibitor 1 is associated with high-grade serous ovarian cancer metastasis and is reduced in patients who have received neoadjuvant chemotherapy

Overview of attention for article published in Frontiers in Cell and Developmental Biology, December 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (77th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

So far, Altmetric has seen 11 X posts from 10 X users, with an upper bound of 43,987 followers.

Plasminogen activator inhibitor 1 is associated with high-grade serous #ovariancancer #metastasis and is reduced in patients who have received #neoadjuvantchemotherapy @LabSpatialNBJ @GlasspoolRos https://t.co/9PshPQpTc8

RT @Lynchsyndromirl: Plasminogen activator inhibitor 1 is associated with high-grade serous ovarian cancer metastasis and is reduced in pat…

RT @Shotoole81: Delighted to see this paper published, well done @NiCheallaigh71 on all your hard work Plasminogen activator inhibitor 1…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 7 additional X posts.